UMass Medical School has adopted use of a standardized clinical trial agreement – the Accelerated Clinical Trial Agreement (ACTA) – to be used by each participating institution and sponsor to reduce contract negotiations for industry-sponsored, multi-center studies.
UMass Medical School has received a four year renewal of its Clinical and Translational Science Award from the National Institutes of Health. The award supports efforts by UMMS and its clinical partner, UMass Memorial, to advance clinical research.
Toxicologist Peter R. Chai, MD, studies the use of Google Glass in the emergency room for virtual consults.
Research at UMMS suggests the immune system plays an unsuspected and surprising role in the progression of Rett syndrome, a severe neurological disorder affecting children. The finding points to the immune system as a promising target for slowing the progression of Rett syndrome.
An advanced smartphone application developed at Worcester Polytechnic Institute to help people with diabetes better manage their weight and blood sugar level and assess the status of chronic foot ulcers, is entering a pilot clinical study at UMass Medical School.
Based on the success of the Inflammatory Bowel Disease Anti-Inflammatory Diet, Barbara Olendzki is collaborating with colleagues in the UMass Center for Microbiome Research to uncover how exactly this diet affects gut bacteria.
Fecal transplant, a novel therapy that Randy Pellish, MD, is exploring with his patients who have recurrent C. diff, is proving to be more than 90 percent effective.
A new study by UMMS researchers finds that severe mortality-associated diseases are less prevalent in families of long-lived individuals than in the general population.